These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 9531961)
1. Estimation of type-specific anti-streptococcal M-protein antibodies with biotinylated peptides in human sera. Kühnemund O; Schumacher F; Casaretto M; Holm SE; Lütticken R APMIS; 1998 Feb; 106(2):288-92. PubMed ID: 9531961 [TBL] [Abstract][Full Text] [Related]
2. Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments. Dale JB Vaccine; 1999 Jan; 17(2):193-200. PubMed ID: 9987154 [TBL] [Abstract][Full Text] [Related]
3. Protective immunity evoked by synthetic peptides of streptococcal M proteins. Beachey EH Adv Exp Med Biol; 1985; 185():193-200. PubMed ID: 2416199 [No Abstract] [Full Text] [Related]
4. Human secretory immune response to streptococcal M protein. Identification of a secretory IgA epitope in the exposed conserved region. Yoshinaga M; Miyata K; Fischetti VA Adv Exp Med Biol; 1997; 418():913-5. PubMed ID: 9331797 [No Abstract] [Full Text] [Related]
5. Antibodies to streptococcal inhibitor of complement function and M peptides in a post-streptococcal glomerulonephritis endemic region of Australia. Sriprakash KS; Hartas J; White A J Med Microbiol; 2002 Jul; 51(7):589-650. PubMed ID: 12132776 [TBL] [Abstract][Full Text] [Related]
6. Human immune response to streptococcal inhibitor of complement, a serotype M1 group A Streptococcus extracellular protein involved in epidemics. Hoe NP; Kordari P; Cole R; Liu M; Palzkill T; Huang W; McLellan D; Adams GJ; Hu M; Vuopio-Varkila J; Cate TR; Pichichero ME; Edwards KM; Eskola J; Low DE; Musser JM J Infect Dis; 2000 Nov; 182(5):1425-36. PubMed ID: 11015234 [TBL] [Abstract][Full Text] [Related]
7. Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population. Yoonim N; Olive C; Pruksachatkunakorn C; Pruksakorn S BMC Microbiol; 2006 Aug; 6():71. PubMed ID: 16895610 [TBL] [Abstract][Full Text] [Related]
8. Immune response against M protein-conserved region peptides from prevalent group A Streptococcus in a North Indian population. Gupta VK; Sekhar S; Dhanda V; Toor D; Kumar R; Chakraborti A J Microbiol Immunol Infect; 2016 Jun; 49(3):352-8. PubMed ID: 25087198 [TBL] [Abstract][Full Text] [Related]
9. Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci. Pruksakorn S; Currie B; Brandt E; Martin D; Galbraith A; Phornphutkul C; Hunsakunachai S; Manmontri A; Good MF Lancet; 1994 Sep; 344(8923):639-42. PubMed ID: 7520963 [TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of a polypeptide fragment of the streptococcal group A M protein conjugated with an acrylic acid N-vinylpyrrolidone copolymer. Lyampert IM; Semenova EN; Sanina VYu ; Puchkova NG; Nekrasov AV Biomed Sci; 1991; 2(4):410-4. PubMed ID: 1797145 [TBL] [Abstract][Full Text] [Related]
11. Intranasal immunisation of mice with a streptococcal peptide-based vaccine. Relf W; Hayman W; Russell-Jones G; Good M Adv Exp Med Biol; 1997; 418():859-61. PubMed ID: 9331788 [No Abstract] [Full Text] [Related]
12. Elevated IgG titer against the C region of streptococcal M protein and its immunodeterminants in patients with poststreptococcal acute glomerulonephritis. Mori K; Ito Y; Kamikawaji N; Sasazuki T J Pediatr; 1997 Aug; 131(2):293-9. PubMed ID: 9290619 [TBL] [Abstract][Full Text] [Related]
13. Structure-based design of broadly protective group a streptococcal M protein-based vaccines. Dale JB; Smeesters PR; Courtney HS; Penfound TA; Hohn CM; Smith JC; Baudry JY Vaccine; 2017 Jan; 35(1):19-26. PubMed ID: 27890396 [TBL] [Abstract][Full Text] [Related]
14. [Distribution of type-specific antibodies to streptococcal lipoproteinase based on population screening data]. Benevolenskaia LI; Iontova IM; Burlev AA; Totolian AA Zh Mikrobiol Epidemiol Immunobiol; 1986 Sep; (9):61-6. PubMed ID: 3538728 [TBL] [Abstract][Full Text] [Related]
15. Opsonic antibodies evoked by hybrid peptide copies of types 5 and 24 streptococcal M proteins synthesized in tandem. Beachey EH; Gras-Masse H; Tarter A; Jolivet M; Audibert F; Chedid L; Seyer JM J Exp Med; 1986 Jun; 163(6):1451-8. PubMed ID: 3519829 [TBL] [Abstract][Full Text] [Related]
16. Association between elevated serum antibody levels to streptococcal M12 protein and susceptibility to dermatomyositis. Ichimiya M; Yasui H; Hirota Y; Ohmura A; Muto M Arch Dermatol Res; 1998 Apr; 290(4):229-30. PubMed ID: 9617445 [No Abstract] [Full Text] [Related]
17. Protective and nonprotective epitopes from amino termini of M proteins from Australian aboriginal isolates and reference strains of group A streptococci. Brandt ER; Teh T; Relf WA; Hobb RI; Good MF Infect Immun; 2000 Dec; 68(12):6587-94. PubMed ID: 11083769 [TBL] [Abstract][Full Text] [Related]
18. [Studies on the measurement of antibody against an extracellular protein associated with nephritogenic streptococci by using the enzyme-linked immunosorbent assay (ELISA)]. Quan JW; Todome Y; Ohkuni H Nihon Ika Daigaku Zasshi; 1984 Jun; 51(3):339-45. PubMed ID: 6378960 [No Abstract] [Full Text] [Related]
19. Type-specific antibodies to purified streptococcal M proteins from potentially rheumatogenic M-types in patients with rheumatic fever and rheumatic heart disease. Thakur A; Singhal S; Prakash K J Med Microbiol; 1996 Dec; 45(6):483-9. PubMed ID: 8958254 [TBL] [Abstract][Full Text] [Related]
20. [A study on streptococcal prevalence in Chiang Mai, Thailand, with special reference to unusual combination between T and M antigens of group A Streptococcus]. Murai T; Inazumi Y; Pruksakorn S Kansenshogaku Zasshi; 1988 Oct; 62(10):869-77. PubMed ID: 3145307 [No Abstract] [Full Text] [Related] [Next] [New Search]